Description
Description
CFX Opus 96 Dx and CFX Opus 384 Dx are open systems offering the ultimate flexibility in commercial assay selection or rapid assay development in a clinical laboratory setting. CFX Opus 96 Dx can multiplex up to 5 targets per well and CFX Opus 384 Dx can multiplex up to 4 targets per well. The instruments offer precise quantification, accurate thermal cycler performance and powerful easy-to-use software.
System Comparison
 CFX Opus 96 Dx System Operational Manual | Data Sheet Inquire for Ordering |
 CFX Opus 384 Dx System Operational Manual | Data Sheet Inquire for Ordering |
|
|---|---|---|
| Features | Multiplex up to 5 targets per sample well on the CFX Opus 96 Dx and up to 4 targets per sample well on the CFX Opus 384 Dx. Optimize assay development with the thermal gradient function. Analyze and generate traceable, audit-ready reports with electronic signature functionality. |
|
CFX Opus Dx Instrument
Sample Block
Optical Detection System
CFX Maestro Dx SE Software
Documentation for CFX Opus Dx System
| Language | CFX Opus Dx Operation Manual | CFX Maestro Dx SE Software Guide |
|---|---|---|
| Chinese | 10000134783 | 10000135541 |
| Croatian | 10000136677 | 10000135541 |
| Czech | 10000135544 | 10000135545 |
| Danish | 10000135546 | 10000135547 |
| English | 10000135538 | 10000134781 |
| French | 10000135550 | 10000135551 |
| German | 10000135548 | 10000135549 |
| Greek | 10000135617 | 10000135618 |
| Hungarian | 10000135619 | 10000135620 |
| Indonesian | 10000135621 | 10000135622 |
| Italian | 10000135623 | 10000135624 |
| Japanese | 10000135628 | 10000135629 |
| Korean | 10000135630 | 10000135631 |
| Lithuanian | 10000135632 | 10000135633 |
| Norwegian | 10000135634 | 10000135635 |
| Polish | 10000135636 | 10000135637 |
| Brazilian Portuguese | 10000135640 | 10000135641 |
| Portuguese | 10000135638 | 10000135639 |
| Romanian | 10000135642 | 10000135643 |
| Spanish | 10000135644 | 10000135645 |
| Swedish | 10000135646 | 10000135647 |
| Thai | 10000135648 | 10000135651 |
| Vietnamese | 10000135652 | 10000135653 |
| Russian | 10000135542 | 10000134784 |
Legal Notice:
CFX Opus 96 Dx System or CFX Opus 384 Dx System with CFX Maestro Dx SE Software are intended to perform fluorescence-based PCR to detect and quantitate nucleic acid sequences. The systems and software are intended for in vitro diagnostic use by trained laboratory technicians. The systems are intended to be used with third-party diagnostic nucleic acid tests which have been manufactured and labeled for diagnostic purposes.
USA: For In Vitro Diagnostic Use. The CFX Opus 96 Dx and CFX Opus 384 Dx Systems meet the requirement for distribution as an in vitro diagnostic device under the US FDA.
Canada: For In Vitro Diagnostic Use. The CFX Opus 96 Dx and CFX Opus 384 Dx Systems meet the requirement for distribution as an in vitro diagnostic device under Health Canada.
Europe: For In Vitro Diagnostic Use. The CFX Opus 96 Dx and CFX Opus 384 Dx Systems meet the requirement of the In Vitro Diagnostic Medical Devices Directive (98/79/EC). The CFX Opus 96 Dx and CFX Opus 384 Dx Systems are for distribution and use in the countries of Austria, Belgium, Bulgaria, Croatia, Cyprus, The Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, The Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland.
Singapore: For In Vitro Diagnostic Use. The CFX Opus 96 Dx and CFX Opus 384 Dx Systems meet the requirements for distribution as an in vitro diagnostic instrument.
No rights are granted by Bio-Rad for the use of high-resolution melt analysis in the fields of human or veterinary in vitro diagnostics. In addition, it is the responsibility of the purchaser to obtain any intellectual property rights which may be required for its specific applications.
